Biofrontera Inc. Warrants (BFRIW) Stock Analysis

Biofrontera Inc. Warrants (BFRIW) is a publicly traded company in the HEALTHCARE sector. It trades at $0.03. This page summarizes the public market data, fundamentals, and frequently asked questions for BFRIW, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $0.03
• EPS: $-1.30
• 52-Week High: $0.28
• 52-Week Low: $0.04

About Biofrontera Inc. Warrants

None

GNG Research Analysis

GNG Research scores Biofrontera Inc. Warrants (BFRIW) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BFRIW.

Frequently Asked Questions

Does BFRIW pay dividends?

Biofrontera Inc. Warrants (BFRIW) does not currently pay a regular dividend.